British Land Acquires Life Science REIT in Golden Triangle Deal

The acquisition marks British Land's strategic entry into the life sciences and innovation property sector, diversifying from its core retail and office portfolio. The five assets are concentrated in the Oxford-Cambridge-London arc, the UK's most active cluster for life sciences and deep technology occupier demand. The 26% discount to NAV reflects broader listed sector pricing but British Land views the long-term development and income potential as highly attractive. The mixed cash and shares structure aligns Life Science REIT shareholders with the enlarged group's performance.